Eiger BioPharmaceuticals, Inc. reports

Company location: Palo Alto, CA
Fiscal year end: 31 December

Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 76-100 of 687 matching filings.

Per page

25

Current page

4

8-K File 001-36183

8-K

Filing date: 14 Apr 2023
Reporting date: 12 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-87931

SC 13G/A

Filing date: 10 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 21 Mar 2023
Reporting date: 17 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270651

S-8

Filing date: 17 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-36183

10-K

Filing date: 17 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36183

8-K

Filing date: 16 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36183

8-K

Filing date: 10 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2023
Reporting date: 01 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87931

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36183

8-K

Filing date: 10 Feb 2023
Reporting date: 06 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-87931

EIGER BIOPHARMACEUTICALS, INC.

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87931

SC 13G/A filing

Filing date: 06 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Feb 2023
Reporting date: 31 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87931

SC 13G/A

Filing date: 02 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jan 2023
Reporting date: 26 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jan 2023
Reporting date: 26 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 25 Jan 2023
Reporting date: 23 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36183

8-K

Filing date: 10 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .